Randomised clinical trial to evaluate postoperative quality of life and body weight loss with the use of EPA-enriched nutrient for resectable gastric cancer patients
Phase 2
- Conditions
- gastric cancer
- Registration Number
- JPRN-UMIN000010568
- Lead Sponsor
- Jichi Medical University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
Not provided
Exclusion Criteria
1. reduced oral intake 2. Treated with icosapentate ethyl 3. supplements containing eicosapentaenoic acid 4. synchronous or metachronous cancer 5. lactate intolerance or allergic reaction to milk/soy 6. hemorrhagic tendency 7. uncontrolled diabetes mellitus 8. Systemic treatment with corticosteroids 9. unstable angina or cardiac infarction within 6 months 10. pulmonary disease under oxygenation 11. Woman with ongoing pregnancy or breast-feeding, or contemplating pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Body weight loss and QOL score at 1/2/3/6 months after surgery
- Secondary Outcome Measures
Name Time Method postoperative functional disorder, lean body mass and skeletal muscle volume at 1/2/3/6 months after surgery, relative performance of Prosure, incidence of surgical morbidity.